This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
3-5 November 2026
RAIAmsterdam, Netherlands

Dr Gilles Divita
Founder and CEO at Divincell
Speaker

Profile

Dr. Gilles DIVITA is founder and CEO of DIVINCELL (FR) and CSO of AANATRA LLC, California (USA). BioPharmaceutical NanoMedicine Start-up pioneering a novel drug delivery technology for the treatment of cancer and genetic diseases. Dr. DIVITA has over 25 years of experience in drug delivery systems, peptide-drugs and oligonucleotide therapeutics. He is the pioneer of the “non covalent cell penetrating peptide-based strategy” for therapeutic delivery and inventor of the peptide-based platform for RNA therapeutic strategy.

Agenda Sessions

  • PEP-NP : Peptide Based Nanoparticle-platform for Targeted Delivery of Functional RNAs

    10:15